Show simple item record

Tissue graft rejection in mice

dc.contributor.authorDeMott-Friberg, Robertaen_US
dc.contributor.authorSchultz, Jane S.en_US
dc.contributor.authorBeals, Theodore F.en_US
dc.date.accessioned2006-09-11T18:09:49Z
dc.date.available2006-09-11T18:09:49Z
dc.date.issued1978-12en_US
dc.identifier.citationSchultz, Jane S.; Beals, Theodore F.; DeMott-Friberg, Roberta; (1978). "Tissue graft rejection in mice." Immunogenetics 6(1): 585-595. <http://hdl.handle.net/2027.42/46754>en_US
dc.identifier.issn1432-1211en_US
dc.identifier.issn0093-7711en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46754
dc.description.abstractA tissue slice-to-kidney bed grafting system is used to study the mechanism of specific tissue rejection (in this case, rejection of liver tissue) over a series of histocompatibility barriers other than the H-2 barrier. Using the method described, it is possible to obtain a pattern or time-course picture of the immunological process, rather than a mean survival time. It is clear from histological observations of these patterns that, although there are considerable differences in numbers of liver grafts which survive for long period's across the several histocompatibility barriers studied, some grafts in almost every case survive the immunological challenge elicited by the genetic barriers. Grafts of liver tissue are therefore similar, but not identical, in survival patterns to grafts of tumor, ovary, and skin. These studies also indicate that immunological mechanisms controlling rejection of tissue over H barriers other than H-2 differ from those controlling rejection over the major histocompatibility barrier in the mouse.en_US
dc.format.extent1135766 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlag; Springer-Verlag New York Inc.en_US
dc.subject.otherCell Biologyen_US
dc.subject.otherImmunologyen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherAllergologyen_US
dc.titleTissue graft rejection in miceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumVeterans Administration Hospital, 48105, Ann Arbor, Michigan; Departments of Human Genetics and Pathology, University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumVeterans Administration Hospital, 48105, Ann Arbor, Michigan; Departments of Human Genetics and Pathology, University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumVeterans Administration Hospital, 48105, Ann Arbor, Michigan; Departments of Human Genetics and Pathology, University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46754/1/251_2005_Article_BF01563948.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF01563948en_US
dc.identifier.sourceImmunogeneticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.